Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of Cyclacel Pharmaceuticals, Inc. of our report dated March 29, 2016 relating to our audits of the consolidated financial statements, which appears in the Annual Report on Form 10-K of Cyclacel Pharmaceuticals, Inc. for the year ended December 31, 2015.
| /s/ RSM US LLP | |
| New York, New York | |
| April 29, 2016 |
